Reza Shojaei: Transforming Canada’s Plasma System for Greater Resilience and Self-Sufficiency
Reza Shojaei, Chief Operating Officer at Canadian Plasma Resources, shared a post on Linkedln:
”Canada’s plasma system is quietly undergoing one of its most important transformations in decades.
Rising demand for immunoglobulins, growing pressure on global supply chains, and years of heavy reliance on imported plasma-derived medicines have pushed plasma fractionation from a technical topic into a strategic health policy priority.
Three forces converging in 2025 were:
- accelerated growth in plasma-derived medicinal products (especially immunoglobulins).
- deliberate expansion of domestic plasma collection.
- regulatory and formulary modernization reshaping how these products are assessed, manufactured, and supplied.
This is not just a market story; it’s a resilience story.
In the latest issue of Blood and Plasma Pulse, we examine:
- where Canada’s plasma fractionation market truly stands today
- how public–private partnerships are re-engineering the supply chain
- why regulatory changes in 2025 matter far beyond compliance
- what still stands between policy ambition and domestic self-sufficiency
For healthcare leaders, regulators, biotech professionals, and anyone thinking about system sustainability, this transition will shape availability, access, and risk for years to come.”
Find more posts featuring Reza Shojae on Hemostasis Today.
-
Oct 6, 2026, 22:43Alessandra Bosch: Pediatric GTH Opens with Regional Experts Convening on Pediatric Hemostasis and Thrombosis
-
Oct 6, 2026, 22:39Managing Thrombotic Risk in Pregnancy – How the Lab May Help – Sysmex Europe
-
Oct 6, 2026, 22:33Ahmet Davut Aksu: A Multi-Objective Approach to Enhance Fibrinolysis, Selectivity, and Inhibition Resistance
-
Oct 6, 2026, 22:29Muhammad Abubakar: New Study on Iron Biology to Be Presented at ASH 2026 and Published in Blood
-
Oct 6, 2026, 22:24David McIntosh: Calling On Decision-Makers to Prioritize Donors and Clinical Access During IPAW 2026
-
Oct 6, 2026, 22:21Zoltan Nagy: With All Eyes on Optogenetics Today, What Can It Do in Megakaryocytes and Platelets?
-
Oct 6, 2026, 22:13Khalid A. Fakhro: Sidra Medicine Hosts RAPID 2026 Advancing Diagnostics and Treatments for Inborn Errors of Immunity
-
Oct 6, 2026, 22:04Denis Oduor: Preparedness for Postpartum Haemorrhage Must Include Preparedness for Blood
-
Oct 6, 2026, 21:57Farhad Moradpour: Health Equity and Public Health – What Drives Anemia Disparities in Ethnic Minority Populations?